- 10-Q here.
- Search for: date of service; several hits in the 64 page PDF document.
- GHDX is up 6% in the week since mentioning the investigation.
- The May 9 document was subsequent to its May 2 investor call.
- Brief Genomeweb report here. I believe it's open access.
In recent news, from March, there was also a compliance investigation of Myriad Genetics billing (Bloomberg here; also here). As often occurs, there is a parallel shareholder lawsuit (here). Myriad share price is up 20% since mentioning the investigation.
Also in March, Natera Inc. settled a Department of Justice investigation into compliance with a $11M payment. Press release here. Natera share price is up 26% since the press release.